ノバルティス

 NVSのチャート


 NVSの企業情報

symbol NVS
会社名 Novartis AG Basel (ノバルティス)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 ノバルティス(Novartis AG)はヘルスケア・ソリューションを提供する持株会社である。同社は医薬品を主としてヘルスケア製品の研究・開発・製造・販売に従事する。同社の事業は医薬品、サンドズ、アルコンとコーポレート活動を含む。医薬品事業は患者と医療提供者のための健康成果を開発するために特許を取得した処方薬を研究、開発、製造、販売、販売する。サンドズ事業は処方薬、有効・執行可能な第三者特許で保護されない医薬品有効成分を開発、製造、販売する。アルコン事業はアイケア製品を研究、開発、製造、販売する。アルコン事業は眼科医療機器と視力ケア製品の提供を行う。同社の製品には、医薬品、腫瘍薬、ジェネリック医薬品、バイオシミラー薬、眼科機器を有する。  ノバルティスはスイスの大手医薬品・バイオテクノロジ―企業。心血管代謝、免疫抑制、皮膚病、網膜、呼吸器など広範な領域で処方薬の研究、開発、生産、販売を展開。また、ジェネリック医薬品の開発、生産、販売に加え、眼科用医療機器、眼科手術器具・消耗品、コンタクトレンズや洗浄液などのアイケア製品も扱う。同社の製品は約180カ国で販売される。  
本社所在地 Lichtstrasse 35 Basel CH-4056 CHE
代表者氏名 Vasant Narasimhan
代表者役職名 Chief Executive Officer Member of the Executive Committee
電話番号 +41 61-324-1111
設立年月日 1895年7月
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 125161人
url www.novartis.com
nasdaq_url
adr_tso
EBITDA (百万ドル) 17697.00000
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 240518.10000
売上高 (百万ドル) 53166.00000
企業価値(EV) (百万ドル) 256702.10000
当期純利益 (百万ドル) 12611.00000
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Novartis AG (ADR) revenues increased 6% to $53.17B. Net income before extraordinary items increased 65% to $12.61B. Revenues reflect Innovative Medicines segment increase of 8% to $34.89B Alcon segment increase of 6% to $7.15B Other Foreign- segment increase of 6% to $22.17B United States segment increase of 4% to $17.56B Germany segment increase of 13% to $4.18B.

 NVSのテクニカル分析


 NVSのニュース

   Global Alzheimer’s disease Market Growth, Size, Opportunity, Share and Forecast 2020-2027||Top Leaders-Pfizer Inc, Novartis AG, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd, Allergan, Teva Pharmaceutical Industries Ltd  2020/12/04 19:04:57 OpenPR
This Alzheimer’s disease report provides complete analysis of the market on global and regional level. It inspects the development rate and the market value dependent on the market elements and growth initiating factors. The market players are
   Big pharma is using AI and machine learning in drug discovery and development to save lives  2020/12/04 18:00:00 Business Insider
Summary List Placement The pharmaceutical industry has been slow-moving when it comes to adopting digital health technology, and pharma companies overall have taken a long time to implement AI and machine learning strategies — making broad-scale digital transformation difficult. There is ample opportunity for drug discovery and development, but it relies on the ability of companies to implement advanced health tech into everyday strategies. While the healthcare industry is rapidly adopting digital tech, the pharma industry is lagging on digital maturity, and any measures even early movers are taking to catch up are patchworked due to a lack of strategy and digital-focused leadership. AI & Machine Learning in the Drug Development Process An incredible amount of time and money goes into drug development — bringing a drug to market costs about $2.8 billion dollars over 12+ years, according to Taconic Biosciences' tally. Utilizing AI and machine learning can help at every stage of the drug discovery process.
   Anti-malarial Drugs Market Insights 2020 | Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG  2020/12/04 08:03:55 OpenPR
Malaria has affected the tropical regions in the world including Africa and Asia, Central and South America, Haiti and the Dominican Republic, some parts of Middle East, and some Pacific islands. The increasing cases of traveler’s malaria is one of
   Pediatric Palliative Care Drugs Market 2020: Industry Size & Share, Business Strategies | Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals  2020/12/04 07:47:46 OpenPR
Pediatric palliative care is a specialized medical care for infants and children living with serious medical conditions such as cancer, genetic disorders, prematurity, heart and lung conditions, neurologic disorders, and others. The goal of palliative care is to improve quality
   Lark Health partnered with Highmark as digital therapy makers continue riding the digital health wave  2020/12/03 14:53:23 Business Insider
Summary List Placement Lark Health partnered with Highmark—the 4th largest BCBS-affiliated organization—to give Highmark members 24/7 access to Lark Health's digital therapeutics (DTx) programs for hypertension and diabetes. DTx companies have been capturing the attention of pharma companies and payers this year: Pharma cos have been strategically pouring cash into DTx firms to capture a slice of the growing DTx market. For example, Boehringer Ingelheim signed a $500 million contract with Click Therapeutics to develop therapies for psychiatric conditions, Bayer invested $100 million in equity stake of digital diabetes startup OneDrop, and Novartis acquired ophthalmology DTx startup Amblyotech. And with the FDA greenlighting multiple DTx treatments—like Akili's ADHD therapy and Pear's schizophrenia program—pharma companies can invest in DTx solutions with more confidence that they'll see an ROI. Payers are wading deeper into the DTx space to pare down their shares of high costs for members with chronic conditions.
   Novartis : des analyses montrent l'efficacité de l'inclisiran  2020/11/13 15:21:00 Boursorama
(CercleFinance.com) - Novartis a présenté aujourd'hui les résultats de deux analyses portant sur l'inclisiran, comme traitement de l'hyperlipidémie, l'excès de lipides dans le sang
   Lipid Injectable Drugs Market With Leading Players like Fresenius Kabi, Abbott Laboratories, Pfizer, B. Braun Melsungen AG, Baxter International, Heron Therapeutics, Novartis AG, ACON Laboratories, CordenPharma International, Boehringer Ingelheim Pharma G  2020/11/13 05:41:30 OpenPR
Lipid injectable has been clinically used as an energy source that provides essential fatty acids and vitamins to hospitalized patients. Lipid emulsions are also used for delivering lipid-soluble therapeutic agents intravenously, owing to the biocompatible nature of the lipid-based delivery
   Global Combination Antibody Therapy Market Thriving Worldwide, Investigated In Latest Research||Novartis AG, Genetech Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Sanofi  2020/11/12 14:11:47 OpenPR
The research report published by Data Bridge Market research report provides the all-inclusive data regarding the market with growth, share, size and recent market trends. Upcoming advancement in the market In this report, Researchers have analyzed Strength, Weakness, opportunities and
   Global Pulmonary Alveolar Proteinosis Drug Market Latest Innovative Solutions to Boost Global Growth, Overview, Driver, Restraints, Deployments and Key Players 2027||Novartis AG, GlaxoSmithKline plc., ALLERGAN, Cipla Inc., The Ritedose Corporation, Boehri  2020/11/12 13:31:22 OpenPR
Data Bridge Market research released a new market study on Pulmonary Alveolar Proteinosis Drug with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis In Pulmonary Alveolar Proteinosis Drug research
   Cytokine Market To Observ Explosive Growth By 2020-2027 | Abbvie, Bayer, Novartis, Roche Holding, Sanofi, Biocon, Pfizer  2020/11/12 12:48:36 OpenPR
Cytokine Market Report covering detailed analysis, Competitive landscape, forecast, and strategies has been added to the Insight Partners. The study covers geographic analysis that includes regions like North America, Europe and Asia-Pacific, South America, Middle East, and Africa. The report
   Viral Hemorrhagic Fever Market : Industry Demand, Share, Future Trends Plans, Growth Opportunities To 2020 - 2027 | Top Players- Merck & Co., Zydus Cadila, Novartis AG, Aurobindo Pharma  2020/10/10 16:56:52 OpenPR
To prepare market research report, certain steps are to be followed for collecting, recording and analysing market data. Viral Hemorrhagic Fever Market research report identifies and analyses the emerging trends along with major drivers, inhibitors, challenges and opportunities in the
   Global Perinatal Infections Market Analysis By Size, Growth Rate, Share, Trends, Key Players, COVID-19 Impact 2020-2027||Arbor Pharmaceuticals, Par Pharmaceutical, Mylan N.V., GlaxoSmithKline Plc., Novartis AG  2020/10/10 15:56:06 OpenPR
“Global Perinatal Infections Market–Industry Trends and Forecast to 2027” New Research Report Added to Databridgemarketresearch.com database. The report width Of pages : 350 Figures: 60 And Tables: 220 in it.The global Perinatal Infections market is highly fragmented and the
   Tinnitus Market : Growth With Industry Study To 2027 | Top Players- Mylan N.V., Amneal Pharmaceuticals LLC., Novartis AG  2020/10/09 15:48:27 OpenPR
Tinnitus market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of tinnitus in
   (Covid 19 Impact Analysis) Global Combination Antibody Therapy Market 2020:Growth Insights and Forecast By Novartis AG, Genetech Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Sanofi  2020/10/09 14:15:55 OpenPR
A new research study from “Data Bridge Market Research” with title combination Antibody Therapy Insights 2020, Global Analysis and Forecast to 2027 provides an in-depth assessment of the Combination Antibody Therapy including key market trends, upcoming technologies, industry
   Biopharmaceuticals Market: Global Analysis By Product Type, Application, Regions, Size, Share Analysis and Key Company Profiles - Abbvie Inc., Amgen Inc., Bristol-Myers Squibb Company, Eli Lily & Co., Johnson & Johnson, Novartis AG  2020/10/09 13:45:12 OpenPR
The Biopharmaceuticals Market research report contains the drivers and restraints for the Biopharmaceuticals Market that are obtained with the help of SWOT analysis, and also shows all the recent developments, product launches, joint ventures, mergers and acquisitions by the several

 関連キーワード  (医薬品 米国株 ノバルティス NVS )

 twitter  (公式ツイッターやCEOツイッターなど)

NVS動画